Great Valley Advisor Group, Inc. Regeneron Pharmaceuticals, Inc. Transaction History
Great Valley Advisor Group, Inc.
- $3.21 Billion
- Q1 2024
A detailed history of Great Valley Advisor Group, Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Great Valley Advisor Group, Inc. holds 654 shares of REGN stock, worth $669,754. This represents 0.02% of its overall portfolio holdings.
Number of Shares
654
Previous 652
0.31%
Holding current value
$669,754
Previous $572,000
9.97%
% of portfolio
0.02%
Previous 0.02%
Shares
10 transactions
Others Institutions Holding REGN
# of Institutions
1,427Shares Held
82.1MCall Options Held
835KPut Options Held
1.46M-
Vanguard Group Inc Valley Forge, PA8.93MShares$9.15 Billion0.17% of portfolio
-
Black Rock Inc. New York, NY8.57MShares$8.78 Billion0.19% of portfolio
-
Jpmorgan Chase & CO New York, NY7.73MShares$7.91 Billion0.68% of portfolio
-
State Street Corp Boston, MA4.84MShares$4.96 Billion0.21% of portfolio
-
Capital World Investors Los Angeles, CA4.65MShares$4.77 Billion0.76% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $110B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...